|
|
||||||||||
|
J Am Coll Cardiol, 2008; 51:599-606, doi:10.1016/j.jacc.2007.11.025 © 2008 by the American College of Cardiology Foundation |
,*
* Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom
Falls and Syncope Service, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
Manuscript received May 16, 2007; revised manuscript received November 8, 2007, accepted November 12, 2007.
* Reprint requests and correspondence: Dr. Steve W. Parry, Falls and Syncope Service, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, United Kingdom. (Email: steve.parry{at}nuth.nhs.uk).
Vasovagal syncope (VVS) has been diagnosed with increasing frequency in older patients since the head-up tilt-table test (HUT) was described over 2 decades ago. The incidence and prevalence of VVS in this age group remains unknown. Older individuals are more likely to display a dysautonomic hemodynamic pattern with a predominantly hypotensive response during HUT. The positivity rates to passive and isoprotenerol-provoked HUT are reduced with age, but positivity rates for glyceryl-trinitrate-induced HUT are comparable with younger subjects. Few studies into treatment strategies have included older subjects. This is a review of the existing literature on the epidemiology, clinical characteristics, diagnostic tools, and treatment strategies for VVS in older patients, highlighting important areas for future research.
| ||||||||
This article has been cited by other articles:
![]() |
J. R. Kapoor Predicting the effectiveness of beta-blocker therapy in vasovagal syncope. J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2372 - 2372. [Full Text] [PDF] |
||||
![]() |
M. P. Tan and S. W. Parry Reply. J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2372 - 2373. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |